One-Carbon Nutrient Supplements May Boost Risk of Type II Endometrial Cancer
New data suggest that, contrary to expectation, the use of supplements containing one-carbon nutrients like folate and vitamins B2, B6, and B12 appears to be associated with an increased risk of type II endometrial cancer.
Acetaminophen Use May Cut Risk of Prostate Cancer
New findings suggest that long-term, regular acetaminophen use may be associated with a lower risk of prostate cancer.
Black Patients With Cancer Are More Willing to Deplete Their Finances to Prolong Life
A new study suggested that black patients with cancer are less hesitant to spend all their financial resources on treatments that prolong life than white patients with cancer.
Patient Navigation Boosts Colorectal Cancer Screening Rate in Ethnically Diverse Patients
A recent study showed that a patient-navigation-based intervention may help increase the rate of CRC screening in typically underserved groups, including low-income, ethnically diverse patients.
Routine Tests and Procedures in Cardiac Patients May Increase Cancer Risk
Researchers have reported that acute myocardial infarction (MI) patients who are exposed to low-dose ionizing radiation from imaging and therapeutic procedures may be at increased risk of cancer.
Using Extracorporeal Photopheresis in the Treatment of Graft-Versus-Host Disease
Extracorporeal photopheresis takes approximately 3 to 4 hours to complete and involves leukapheresis, separation of the buffy coat, photoactivation, and finally reinfusion.
Population Stratification and Cancer Risk Assessment: An Interview With Jill Barnholtz-Sloan, PhD
Population stratification refers to differences in allele frequencies between cases and controls, resulting from systematic differences in ancestry, as opposed to associations between genes and disease.
The Landscape of Chemoprevention in Lung Cancer: A Conversation With Waun K. Hong, MD, PhD
Over the past 25 years, multiple lung cancer chemoprevention trials have missed the mark with agents that looked good on paper but lacked the molecular biology support to make a difference.
Chemotherapy Improves Survival in Older Women With Advanced ER-Negative Breast Cancer
Older women with estrogen receptor (ER)-negative metastatic breast cancer have a 39% lower risk of all-cause mortality if they receive chemotherapy within 6 months of their diagnosis.
Iloprost Causes Regression of Endobronchial Dysplasia in Former Smokers
Results of a phase II trial showed that former smokers had significant regression of endobronchial dysplasia when treated with iloprost.
Cost-Effectiveness of 70-Gene MammaPrint Signature in Node-Negative Breast Cancer
Breast cancers with similar clinicopathologic characteristics may have strikingly different outcomes.
Heavy Beer Drinking Increases Risk of Gastric Cancer
Investigators in a large cohort study reported that heavy alcohol consumption, particularly beer, significantly increases the risk of gastric cancer.
Hedgehog Pathway Inhibitor GDC-0449 Reduces Lesion Size in Patients With Basal Cell Carcinoma
Patients with basal cell carcinoma had an eightfold decrease in lesion area when treated with GDC-0449
Digoxin Found to Be Effective in the Fight Against Prostate Cancer
A search for potential chemopreventive agents for prostate cancer uncovered an unlikely candidate in digoxin, one of the oldest drugs for cardiovascular disorders
Studies Find That Talc-Based Powder Increases the Risk of Ovarian Cancer
Long-term use of talc-based powder significantly increased the risk of invasive ovarian cancer in a large case-control study
Menthol Cigarettes Not More Likely to Cause Lung Cancer Than Nonmenthol Cigarettes
New results appear to undercut the longstanding notion that individuals who smoke menthol cigarettes have a higher risk of lung cancer than those who smoke nonmenthol cigarettes
Emerging Cancer Vaccines Appear to Be on Track for Major Advances
Both industry and clinical sources agree that cancer vaccine research is finally on the right track to achieve major advances in treatment.
'Dark Energy' Within the Human Cell
Recently, significant attention has been focused on dark energy, despite our inability to directly detect it, because it represents 72% of everything in the universe
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.